Tepezza is a medication that has been approved by the FDA for the treatment of thyroid eye disease (TED). This condition, also known as Graves’ ophthalmopathy, is an autoimmune disorder that affects the muscles and tissues around the eyes, causing symptoms such as eye bulging, double vision, and eye pain.

Tepezza works by targeting a specific protein that is overexpressed in patients with TED, helping to reduce inflammation and swelling in the eye tissues. Clinical trials have shown that Tepezza can significantly improve symptoms and reduce the severity of TED in patients, leading to improved quality of life and better overall eye health.

As with any medication, Tepezza may cause side effects in some patients. These can include muscle spasms, nausea, and changes in taste. It is important to discuss any potential side effects with your healthcare provider before starting treatment with Tepezza.

It is also important to follow your healthcare provider’s instructions carefully when taking Tepezza. This medication is typically administered through intravenous infusions, which are usually given once every three weeks for a total of eight infusions. It is important to attend all scheduled appointments and follow-up visits to monitor your progress and adjust your treatment plan as needed.

If you have been diagnosed with thyroid eye disease and are considering treatment with Tepezza, talk to your healthcare provider to see if this medication is right for you. With proper medical supervision and adherence to your treatment plan, Tepezza can help improve your symptoms and overall eye health.